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Abstract

Mandelate racemase (MR), a member of the enolase superfamily, catalyzes
the Mg2+-dependent interconversion of the enantiomers of mandelate. Several
α-keto acids are modest competitive inhibitors of MR [e.g., mesoxalate (Ki =
1.8 ± 0.3 mM) and 3-fluoropyruvate (Ki = 1.3 ± 0.1 mM)], but, surprisingly,
3-hydroxypyruvate (3-HP) is an irreversible, time-dependent inhibitor
(kinact /KI = 83 ± 8 M–1 s–1). Protection from inactivation by the competitive
inhibitor benzohydroxamate, trypsinolysis and electrospray ionization tandem
mass spectrometry analyses, and X-ray crystallographic studies reveal that 3HP undergoes Schiff-base formation with Lys 166 at the active site, followed
by formation of an aldehyde/enol(ate) adduct. Such a reaction is
unprecedented in the enolase superfamily and may be a relic of an activity
possessed by a promiscuous progenitor enzyme. The ability of MR to form and
deprotonate a Schiff-base intermediate furnishes a previously unrecognized
mechanistic link to other α/β-barrel enzymes utilizing Schiff-base chemistry
and is in accord with the sequence- and structure-based hypothesis that
members of the metal-dependent enolase superfamily and the Schiff-baseforming N-acetylneuraminate lyase superfamily and aldolases share a
common ancestor.

One of the first enzyme superfamilies recognized was the
enolase superfamily,1 whose members share a common partial
reaction (i.e., the metal-assisted, Brønsted-base-catalyzed abstraction
of the α-proton from a carboxylate substrate to form an enolate) 2-5
and a common protein fold [i.e., a modified (α/β)8-barrel (TIM barrel)
bearing the catalytic residues at the C-terminal ends of the β-strands
and an N-terminal domain that caps the active site conferring
substrate specificity and excluding solvent]. 6-8 Studies of members of
the enolase superfamily have afforded important insights into enzyme
evolution and developing strategies for assigning the correct functions
to proteins identified in genome projects. 3,9-12 The well-characterized
Biochemistry, Vol 54, No. 17 (May 5, 2015): pg. 2747-2757. DOI. This article is © American Chemical Society and
permission has been granted for this version to appear in e-Publications@Marquette. American Chemical Society does
not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission
from American Chemical Society.

2

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

archetype of this superfamily, mandelate racemase (MR, EC 5.1.2.2)
from Pseudomonas putida, catalyzes the Mg2+-dependent, 1,1-proton
transfer reaction that interconverts the enantiomers of mandelate and
has served as a useful paradigm for understanding how enzymes
catalyze the rapid α-deprotonation of a carbon acid substrate with a
relatively high pKa value.13
MR utilizes a two-base mechanism with Lys 166 and His 297
abstracting the α-proton from (S)- and (R)-mandelate, respectively
(Scheme 1). A variety of β/γ-unsaturated compounds,14-21 as well as
trifluorolactate,22 serve as substrates for the enzyme. Recently, we
showed that the substrate–product analogue 3,3,3-trifluoro-2hydroxy-2-(trifluoromethyl)propionate [TFHTP (Chart 1)] is a potent
competitive inhibitor of MR (Ki = 27 μM) and that its unexpectedly high
binding affinity arises from both intimate interactions between the
trifluoromethyl groups and the hydrophobic pocket at the active site,
and formation of salt bridges between the carboxylate of TFHTP and
the active site Brønsted acid–base catalysts Lys 166 and His 297.23
Recognizing that these active site bases can be exploited as binding
determinants for inhibitors, we showed that tartronate is also a
competitive inhibitor of MR (Ki = 1.8 mM), binding with its glycolate
moiety chelating the Mg2+ ion and with the remaining carboxylate
group interacting with and bridging the active site Brønsted acid–base
catalysts.23 Our interest in understanding the role of the active site
Brønsted acid–base catalysts as binding determinants led us to
interrogate the active site using three-carbon α-keto acids as
tartronate analogues. Most unexpectedly, we discovered that 3hydroxypyruvate (3-HP) is an irreversible inhibitor of MR, reacting at
the active site to form a Schiff-base intermediate that is subsequently
deprotonated to form an aldehyde/enol(ate) adduct. Such a reaction
has not been reported previously for any member of the enolase
superfamily and suggests a mechanistic link to other enzyme
superfamilies utilizing Schiff-base chemistry.
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Chart 1. Structures of Ligands

Scheme 1. Reaction Catalyzed by Mandelate Racemase

Materials and Methods
General
(R)-Mandelic acid, lithium 3-hydroxypyruvate (3-HP), sodium
mesoxalate monohydrate, benzoylformic acid, sodium pyruvate,
benzohydroxamic acid, sodium 3-fluoropyruvate monohydrate (3-FP),
and all other reagents, unless mentioned otherwise, were purchased
from Sigma-Aldrich Canada Ltd. Circular dichroism (CD)-based assays
were conducted using a JASCO J-810 spectropolarimeter with a
thermostated, water-jacketed cell holder. High-resolution electrospray
ionization (ESI) mass spectrometry (MS) was conducted using a
Brüker microTOF Focus orthogonal ESI-time-of-flight mass
spectrometer operating in positive ion mode.
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Concentration Correction for 3-HP
Elemental analysis (Canadian Microanalytical Services Inc.) was
conducted on the lithium salt of 3-HP purchased from Sigma-Aldrich to
obtain an accurate estimate of the extent of hydration. On the basis of
the presence of 26.13% carbon and 3.63% hydrogen in the sample,
the calculated molecular weight of 3-HP was 137.89, which
corresponds to C3H3O4Li·∼1.5H2O.

Site-Directed Mutagenesis
The pET52b(+)-wtMR plasmid24 was used as the template to
create the H297N mandelate racemase (MR) mutant by performing
polymerase chain reaction (PCR)-based site-directed mutagenesis
using the QuikChange Site-directed Mutagenesis Kit (Stratgene) and
following the protocols described by the manufacturer. Polymerase
chain reactions were conducted using PfuTurbo DNA polymerase (Bio
Basic Inc.). The forward and reverse synthetic deoxyoligonucleotide
primers (Integrated DNA Technologies, Inc.) used to construct the
mutant were 5′-CCAATGTCCAGCAACCTGTTCCAAGAAATCAGC-3′ and
5′-GCTGATTTCTTGGAACAGGTTGCTGGACATTGG-3′, respectively. The
codons specifying the relevant amino acid are underlined, and the
altered bases are given in boldface. Potential mutant plasmids were
used to transform competent Escherichia coli DH5α cells. DH5α cells
were used for plasmid maintenance and for all sequencing reactions.
The mutant open reading frame was sequenced using commercial
automated DNA sequencing (Robarts Research Institute) to ensure
that no other alterations of the nucleotide sequence had been
introduced.

Enzyme Purification
Recombinant wild-type (wtMR) and H297N MR from
Pseudomonas putida were overexpressed in and purified from E. coli
BL21(DE3) cells transformed with the pET-52b(+)-wtMR and pET52b(+)-H297N-MR plasmids, respectively. The pET-52b(+)-wtMR
plasmid containing the MR variant open reading frame encodes the MR
gene product (MASWSHPQFEKGALEVLFQGPGYHM1...MR) with an NBiochemistry, Vol 54, No. 17 (May 5, 2015): pg. 2747-2757. DOI. This article is © American Chemical Society and
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terminal StrepII tag (underlined; M 1 represents the first amino acid of
wild-type MR).24 The wild-type and mutant enzymes were purified by
affinity chromatography using Strep-Tactin Superflow resin (IBA
GmbH) and an ÄKTA FPLC instrument (GE Healthcare) as described
previously.24 Upon elution from the column, the enzyme was dialyzed
against storage buffer [100 mM HEPES buffer (pH 7.5) containing 3.3
mM MgCl2, 200 mM NaCl, and 10% (v/v) glycerol] and stored at
−20 °C. The purity of the enzyme preparation (≥99%) was checked
using 12% sodium dodecyl sulfate–polyacrylamide gel electrophoresis
(SDS–PAGE). StrepII-tagged MR has the same activity as the wildtype enzyme;24 consequently, the StrepII tag was not removed from
the enzymes.

Enzyme Assays
MR activity was assayed using a CD-based assay by following
the change in ellipticity of mandelate at 262 nm using a thermostated
quartz cuvette with a 1-cm light path (unless otherwise indicated) as
described by Sharp et al.25 All assays (total volume of 2 mL) were
conducted at 25 °C in Na+-HEPES buffer (0.1 M, pH 7.5) containing
MgCl2 (3.3 mM), BSA [0.005% (w/v)], and (R)-mandelate as the
substrate. The concentration of MR was determined from its
absorbance at 280 nm using an extinction coefficient of 53400 M–1 cm–
1
, which was calculated using the ProtParam tool available on the
ExPASy server (http://web.expasy.org/protparam).26 All kinetic
parameters were determined in triplicate, and average values are
reported. The reported errors are the standard deviations.

Initial Screening of α-Keto Acids for Time-Dependent
Inhibition of MR
Wild-type MR (32.7 nM) was incubated with either pyruvate
(10.0 μM), mesoxalate (10.0 μM), 3-FP (10.0 μM), benzoylformate
(10.0 μM), or 3-HP (8.0 μM) in the presence of BSA [0.05% (w/v)] at
25 °C for 0, 6, 12, 18, and 24 min. At each time point, 200 μL of the
enzyme/inhibitor mixture was added to assay buffer containing (R)mandelate to determine the MR activity. The residual MR activity was
measured using the CD-based assay by following the change in
ellipticity of mandelate at 262 nm for 3 min in a quartz cuvette with a
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1-cm light path (0.5-cm light path length when the inhibition by
benzoylformate was assessed). The final concentrations of MR, BSA,
inhibitor, and (R)-mandelate in the 2.0 mL assay mixture were 3.3 nM,
0.005% (w/v), 1.0 μM (except for that of 3-HP, which was 0.8 μM),
and 10 mM, respectively. Simultaneously, a control reaction mixture
containing wild-type MR (32.7 nM) was incubated in assay buffer at
25 °C for 0 and 30 min to determine the rate of loss of MR activity
under the incubation conditions in the absence of inhibitor. Similar
time-dependent inhibition experiments were also conducted for
pyruvate, mesoxalate, benzoylformate, and 3-FP at a greater inhibitor
concentration (2 mM) for 0 and 10 min. The final concentrations of
MR, inhibitor, and (R)-mandelate were equal to 3.3 nM, 0.2 mM, and
10 mM, respectively, in a total reaction volume of 2.0 mL for the
activity assays.

Inhibition of MR by Mesoxalate and 3-FP
Inhibition experiments were conducted in Na+-HEPES buffer (0.1
M, pH 7.5) containing MgCl2 (3.3 mM), BSA [0.005% (w/v)], (R)mandelate (0.25–10.0 mM), MR (3.0 nM), and either mesoxalate (0,
1.0, 2.0, and 4.0 mM) or 3-FP (0, 0.75, 1.5, and 3.0 mM) in a total
reaction volume of 2.0 mL. The apparent kinetic constants Vmax and Km
were determined by fitting eq 1 to the initial velocity data using
nonlinear regression analysis and KaleidaGraph version 4.02 from
Synergy Software. Competitive inhibition constants (K i) were
determined from plots of the apparent Km/Vmax values versus inhibitor
concentration in accord with eq 2.

(1)

(2)

Inactivation of MR by 3-HP
The kinetic parameters for the time-dependent inhibition of MR
by 3-HP were determined by incubating wild-type MR (32.7 nM) with
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various concentrations of 3-HP (0, 3.99, 7.98, 11.97, and 15.95 μM) in
the presence of BSA [0.05% (w/v)] at 25 °C for 0, 6, 12, 18, and 24
min. At each time point, an aliquot (200 μL) of the reaction mixture
was added to the assay solution (total volume of 2.0 mL) containing
(R)-mandelate (final concentration of 10 mM) to determine the
remaining MR activity as described above. The observed pseudo-firstorder rate constant for the inactivation of MR (kobs ) at each inhibitor
concentration was determined by fitting eq 4 (based on eq 3) to the
data for the loss of MR activity as a function of time. The values of kobs
were then plotted against the concentration of 3-HP to determine the
efficiency of inactivation (kinact/KI) using eq 6 (based on eq 5, because
[3-HP] ≪ KI). Because saturation was not observed, only the apparent
second-order rate constant (k2 or kinact/KI) could be determined.

(3)

(4)

(5)

(6)
MR (32.7 nM) that had been completely inactivated by 3-HP (15.95
μM) was dialyzed for 4.5 and 10.5 h at 4 °C against HEPES assay
buffer (pH 7.5) to test the reversibility of the inhibition. After dialysis,
no significant MR activity was regained relative to that of a control
sample containing wild-type MR in the absence of 3-HP.

Inactivation of MR by 3-HP in the Presence of
Benzohydroxamate (BzH)
MR (32.71 nM) was incubated with 3-HP (15.95 μM) in the
presence BSA [0.05% (w/v)] and various concentrations of BzH (0, 5,
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10, and 20 μM) at 25 °C. At various time points (0, 6, 12, 18, and 24
min), an aliquot (200 μL) of the reaction mixture was added to the
assay solution (total volume of 2.0 mL) containing (R)-mandelate
(final concentration of 10 mM) to determine the amount of MR activity
remaining as described above. The observed pseudo-first-order rate
constants for the inactivation of MR (kobs ) by 3-HP (15.95 μM) in the
presence of various concentrations of BzH were determined by fitting
eq 4 to the data for loss of MR activity as a function of time.

Mass Spectrometry Analysis of MR Inactivated by 3-HP
Wild-type MR (0.7 mg/mL) and H297N MR (0.98 mg/mL) were
incubated with 3-HP (4.0 mM) at 25 °C until the activity of wild-type
MR was undetectable using the CD-based assay [assay concentrations
of MR and (R)-mandelate of 327 nM and 10 mM, respectively]. A
control sample containing wild-type MR was incubated for the same
time period in the absence of 3-HP. After complete inactivation of wildtype MR by 3-HP, an aliquot (20 μL) was removed from each reaction
mixture and subjected to SDS–PAGE (12%).

In-Gel Digestions
Gel bands from SDS–PAGE corresponding to MR and H297N MR
were excised from the gel and rinsed with deionized water (2 × 300
μL). The excised gel strips were then cut into cubes (∼1 mm3) and
processed using an automated system for conducting in-gel protein
digestions (Investigator Progest, Genomic Solutions). Briefly, the
protein in the gel cubes was reduced using dithiothreitol (10 mM),
carboxamidomethylated using iodoacetamide (100 mM), and digested
for 12 h at 37 °C using sequencing-grade trypsin (Promega). The
peptides were extracted from the gel pieces by three 20 min
incubations with a solution (30 μL) containing acetonitrile (50%) and
formic acid (5%) in LC–MS-grade water with gentle agitation. The
extracts were pooled and dried using a vacuum concentrator (Speed
Vac Concentrator, SPD 111 V-230, Thermo Electron Corp.) and finally
resuspended in LC–MS-grade water (15 μL) containing acetonitrile
(3%) and formic acid (0.5%).
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LC–ESI-MS/MS and Data Analysis
LC–ESI-MS/MS was conducted using a nanoflow HPLC system
(UltiMate 3000, Dionex) connected to a hybrid ion trap-orbitrap highresolution tandem mass spectrometer (Velos Pro, Thermo Scientific)
operated in data-dependent acquisition (DDA) mode. Each sample (1
μL) was injected onto a capillary column (C18 Onyx Monolithic, 0.10
mm × 150 mm, Phenomenex) at a flow rate of 300 nL/min. Samples
were sprayed at 1.6 kV using fused silica noncoated emitters (20 μm
inside diameter with a 10 μm ID tip, PicoTip Emitter from New
Objective). Chromatographic separation was achieved using a linear
gradient from 3 to 35% solvent B in solvent A over 30 min and then
increasing the level of solvent B to 95% over 5 min (solvent A
consisted of 0.1% formic acid in water and solvent B 0.1% formic acid
in acetonitrile). The raw data files were acquired (Xcalibur, Thermo
Fisher) and exported to Proteome Discoverer software version 1.4
(Thermo Fisher) for peptide and protein identification using the
Sequest database search algorithm.27 Carbamidomethyl cysteine and
oxidized methionines were selected as static and dynamic
modifications, respectively. Peptide to spectrum match (PSM)
validation was conducted using high-confidence XCorr threshold values
of 1.9, 2.3, and 2.6 for doubly, triply, and more highly charged
precursors.

Analysis of H297N MR-3-HP Reduced with NaCNBH3
H297N MR (0.98 mg/mL) was incubated with 3-HP (4.0 mM) in
assay buffer at 25 °C for 30 min. Sodium cyanoborohydride (10 μL of
a 1 M stock solution) was then added to the reaction mixture (total
volume of 200 μL) to give a final concentration of 50 mM, and the pH
was adjusted to 7.0 using HCl. The reaction mixture was then
incubated for an additional 30 min. Finally, an aliquot of the reaction
mixture (20 μL) was subjected to SDS–PAGE (12%) and analyzed
using mass spectrometry as described above.

X-ray Crystallography
All crystals of wild-type MR were obtained at room temperature
by the batch crystallization method. The protein solution consisted of
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MR (6.0 mg/mL) purified as described above, in the presence of Na +HEPES buffer (50 mM, pH 7.5) containing MgCl 2 (3.3 mM) and 3-HP
(20 mM). The batch reservoir solution was composed of sodium
acetate (140 mM, pH 4.5), KCl (280 mM), and pentaerythritol
propoxylate 426 (PEP 426; 46%). The protein solution and reservoir
solution were gently mixed in a 1:1 ratio to a final volume of 20 μL,
and 10 μL of this mixture was pipetted into a lightly greased
crystallization well and sealed with a glass coverslip lined with mineral
oil. Crystals grew spontaneously for 17 h, resulting in hexagonally
shaped crystals. These crystals were looped directly from the wells to
be flash-cooled in liquid nitrogen for storage.

Data Collection, Structure Determination, and
Refinement
X-ray diffraction data for MR cocrystallized with 3-HP were
collected at the Advanced Photon Source (APS) beamline LS-CAT-21ID-G on a Rayonix MarMosaic 300 CCD detector, with an X-ray
wavelength of 0.979 Å. Diffraction images were processed using
HKL2000.28 The structure was determined by molecular replacement
using the wild-type MR enzyme [Protein Data Bank (PDB) 2MNR] as
the search model with Phaser.29 The molecular replacement models
were extended by several rounds of manual model building with
COOT30 and refinement with REFMAC31 using an automatically
generated geometric/X-ray weighting term. Water molecules were
added to the model in COOT with subsequent manual verification. On
the basis of protein purification conditions and the well-established
metal binding preference of MR, a Mg 2+ ion was modeled into the
active site, despite the fact that a modeled Mg2+ ion does not satisfy
all of the observed electron density at this position.

Results and Discussion
Structure–Activity Study
We examined the effect of the α-keto acids 3-HP, mesoxalate,
3-fluoropyruvate (3-FP), and pyruvate on MR activity (Chart 1).
Mesoxalate, which is fully hydrated in water (i.e., C2 gem-diol),32 was
a competitive inhibitor of MR with respect to (R)-mandelate [Ki = 1.8
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± 0.3 mM (Figure 1S of the Supporting Information)], binding with the
same affinity as tartronate (K i = 1.8 mM),23 suggesting that the
glycolate-like moiety present in both ligands chelates the Mg 2+ and the
second carboxylate forms a salt bridge with the active site Brønsted
acid–base catalysts, thereby compensating for the loss of hydrophobic
interactions.23 Pyruvate, which exists as the keto form under the assay
conditions,33,34 exhibited only 40% inhibition of MR activity at a
concentration of 25 mM [i.e., Ki ≈ 20 mM, assuming competitive
inhibition with 1 mM (R)-mandelate; Km = 1.2 mM]. This low binding
affinity is similar to that of lactate (Ki ≈ 30 mM)20 and likely arises
because the methyl group is not sufficiently hydrophobic, nor can it
form salt bridges with the Brønsted acid–base catalysts. MR bound 3FP with an affinity [Ki = 1.3 ± 0.1 mM (Figure 2S of the Supporting
Information)] ∼15-fold greater than the affinity it exhibited for
pyruvate, due to either dipolar interactions (rather than true Hbonds)35,36 with the active site acid–base catalysts or enhanced
hydrophobic interactions.37
In aqueous solutions, α-keto acids can exist as hydrates (gemdiols) to varying degrees.33 The hydration state will determine the
hybridization of C2 and could affect the binding of α-keto acids at the
active site of MR. Pyruvate exists as the keto form (>92%) at pH
6.8,33,34 and benzoylformate (an α-keto acid examined previously)38 is
also expected to be in the keto form (>90%) at the assay pH.39 Our
observations that MR binds pyruvate (Ki ∼ 20 mM) and benzoylformate
(Ki = 0.65 mM)38 with affinities similar to those for lactate (Ki = 30
mM)20 and (R)-mandelate (Km = 0.81 mM),38 respectively, suggest
that the enzyme does not distinguish between sp 2 and sp3
hybridization at C2 in the ground state. Mesoxalate and 3-FP are 100%
and >90% hydrated, respectively, in aqueous solutions. 32,40-42
However, in the active site of MR, it is possible that coordination of the
metal ion could lead to dehydration of the gem-diols, yielding the
corresponding keto species.43 It is unlikely, however, that this latter
possibility would result in a significant alteration of the binding affinity
considering our observations with pyruvate and lactate, and
benzoylformate and mandelate, mentioned above.
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Inactivation by 3-HP
Surprisingly, 3-HP (8.0 μM) showed time-dependent inhibition,
while the other α-keto acids did not show such behavior at a
concentration of 10 μM (Figure 1a) or 2 mM (Figure 3S of the
Supporting Information). Dialysis of the inactive 3-HP-treated MR
against assay buffer for ∼11 h did not restore enzymatic activity,
indicating that the inactivation was irreversible. The inactivation of MR
by 3-HP followed pseudo-first-order kinetics (Figure 1b), and the
observed pseudo-first-order rate constants (kobs ) exhibited a linear
dependence on the concentration of 3-HP (Figure 1c). Saturation was
not observed at 3-HP concentrations of ≤16 μM, and at higher
concentrations of 3-HP, we were not able to obtain accurate kobs values
because the loss of the MR activity was too rapid (relative to the assay
duration of 3 min). Consequently, we were not able to differentiate
between a kinetic mechanism for inactivation following a single step
and a two-step mechanism with the reversible formation of a binary
complex between MR and 3-HP. The slope from the plot of kobs versus
the concentration of 3-HP gave an apparent second-order rate
constant for inactivation (k inact/K I or k2) with a value of 83 ± 8 M –1 s–1.
The observed rate of inactivation by 3-HP was reduced in the presence
of the reversible competitive inhibitor benzohydroxamate (BzH)
(Figure 1d), indicating that 3-HP likely binds at the active site.

Figure 1. Time-dependent inhibition of MR activity. (a) Time-dependent inactivation of
MR (32.7 nM) incubated with either 3-HP (8.0 μM, ●), mesoxalate (10 μM, ▽),
pyruvate (10 μM, □), benzoylformate (10 μM, △), 3-FP (10 μM, ◇), or no inhibitor (○)
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at 25 °C. The reaction mixture was diluted 10-fold by addition of assay buffer
containing (R)-mandelate (final concentration of 10 mM), and the initial rates were
measured at the indicated times. (b) Time-dependent inactivation of MR (32.7 nM)
incubated with various concentrations of 3-HP: 0 (●), 4.0 (▲), 8.0 (■), 12.0 (▼), and
16.0 (◆) μM at 25 °C. The initial rates were measured at the indicated time points. (c)
Observed pseudo-first-order rate constants for inactivation (kobs ) plotted as a function
of 3-HP concentration. The slope yields a value for the apparent second-order rate
constant for the efficiency of inactivation (kinact/KI) equal to 83 ± 8 M–1 s–1. (d)
Protection against 3-HP-dependent inactivation of MR by 0 (◇), 5 (△), 10 (□), and 20
(▽) μM benzohydroxamate at 25 °C. MR was incubated with 3-HP (16.0 μM), and the
initial rates were measured at the indicated time points as described above. The value
for the control reaction, in the absence of 3-HP, is also shown (○). Experimental details
may be found in Materials and Methods.

Site of Covalent Modification
To identify the residue(s) modified upon inactivation by 3-HP, 3HP-modified MR (3-HP–MR) and an untreated sample of MR (controlMR) were subjected to SDS–PAGE followed by in-gel digestion with
trypsin. The resulting proteolytic cleavage peptides were analyzed
using LC–ESI-MS/MS. For both control-MR and 3-HP–MR, ≥95%
sequence coverage was obtained. MS data showed identical peptides in
both the control-MR and 3-HP–MR samples with the exception of the
cleavage fragment TKIGYPALDQDLAVVR (TK-peptide, residues 165–
180 with one missed cleavage site). The TK-peptide in the 3-HP–MR
sample gave two m/z peaks. One peak corresponded to an unmodified
peptide (MH +, m/z 1758.97) that was also observed in control-MR,
suggesting that either the enzyme was partially modified or some
modification was reversed during sample preparation. The other TKpeptide had a higher m/z value (MH+, m/z 1844.98), consistent with
MR being modified by addition of a group with a mass of 86 Da.
Internal fragmentation of the triply charged modified TK-peptide
(monoisotopic, m/z 615.66) and the triply charged unmodified TKpeptide (monoisotopic, m/z 586.99) precursors gave a mass increment
of 86 Da between the b 2+ ions arising from the modified (316.34 Da)
and unmodified (230.27 Da) TK-peptides, suggesting modification of
either Thr 165 or Lys 166 (Figure 2a,b). Modification of Thr 165
seemed unlikely because the side chain of this residue is directed away
from the active site, and it is difficult to account for the increment of
86 Da. The remaining b and y ions corresponded to the expected
amino acid sequence of the TK-peptides. Upon treatment of H297N MR
with 3-HP and subsequent LC–ESI-MS/MS analysis, no modified tryptic
peptides were observed, suggesting that His 297 is required for
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irreversible inhibition. Thus, our kinetic and MS/MS results suggest
that 3-HP modifies Lys 166, with the resulting adduct having a
molecular mass of 86 Da.

Figure 2. ESI-MS/MS analysis of TK-peptides. Mass spectra for the triply charged ion
of the TK-peptide from (a) untreated wild-type MR (m/z 586.995; MH + = 1758.971
Da) and (b) 3-HP-treated wild-type MR (m/z 615.664; MH + = 1844.976 Da) reveal
modification of the tryptic peptide (with one missed cleavage site), increasing the
mass by 86 Da. The increase in mass of the b2+ ion by 86 Da suggests modification of
Lys 166 (bold in panel b). (c) ESI-MS/MS analysis of the triply charged ion (m/z
616.329; MH + = 1846.97 Da) of the TK-peptide (residues 165–180) arising from the
trypsin-digested 3-HP-modified H297N MR treated with NaCNBH 3 reveals modification
of the active site Lys 166, increasing the mass by 88 Da. This mass is consistent with
reduction of the Schiff-base adduct.

Mechanism of Inactivation
A possible mechanism accounting for our observations involves
the reversible formation of a Schiff base (imine) between the ε-NH2
group of Lys 166 and the α-carbonyl of 3-HP [C2 mechanism (Scheme
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2)], similar to the mechanism proposed for the inactivation of Nacetylneuraminate lyase (NAL)44 and dihydrodipicolinate synthase
(DHDPS)45 by 3-HP. Subsequent deprotonation of the Schiff base
(presumably by His 297) would yield an enol or enolate [i.e.,
enol(ate)] (86 Da), which could tautomerize to yield a covalent
aldehyde adduct. Incubation of H297N MR with 3-HP, followed by
treatment with NaCNBH 3, and subsequent separation by SDS–PAGE
and analysis using LC–ESI-MS/MS revealed that Lys 166 of the TKpeptide was modified by a group with a mass of 88 Da (Figure 2c),
consistent with reduction of the Schiff base and in accord with the
proposed inactivation mechanism. In addition, we observed two 88 Da
adducts arising from the nonspecific modification of Lys 207 and Lys
238 located away from the dimer interface on the surface of the
enzyme (data not shown). Such adducts would be expected
considering that imines may form spontaneously at other sites bearing
a primary amino group.46,47

Scheme 2. Proposed Mechanisms for Inactivation of MR by 3-HP Giving Rise to an 86
Da Adduct
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Alternatively, 3-HP may undergo tautomerization either in
solution or within the active site to yield tartronate semialdehyde. 48
Schiff-base formation between Lys 166 and the aldehyde [C3
mechanism (Scheme 2)], followed by deprotonation, also yields an
adduct with a mass of 86 Da and is consistent with our LC–ESI-MS/MS
observations.

Structural Studies
To distinguish between these two mechanistic possibilities, we
determined the X-ray crystal structure of MR inactivated by 3-HP at
1.65 Å resolution (Table 1). The electron density clearly indicates bond
formation occurs between the ε-NH2 group of Lys 166 and C2 of 3-HP
in accord with the C2 mechanism (Figure 3 and Figure 4S of the
Supporting Information). The structure was refined by defining a single
bond between the ε-NH2 group of Lys 166 and C2 of 3-HP, and the 3HP adduct was further refined in two alternative conformations: major
(70%) and minor (30%) conformations of either the (E)-enol(ate) or
the aldehyde. Although it is not possible to determine whether the
product adduct exists as the aldehyde or enol(ate) tautomer from the
crystal structure, the enol(ate) may be preferred because enolase,
which has a similar active site architecture, is strongly inhibited by the
enolate of d-tartronate semialdehyde phosphate. 49,50 Certainly, the
active site of MR is optimized to stabilize an enolate in accord with its
ability to catalyze racemization, and Nε2 of His 297 is 2.9 Å from the
terminal oxygen of the major adduct so that it is capable of stabilizing
the enol(ate) through H-bonding (Figure 3). The inability of 3-FP to
inactivate MR indicates that the formation of either the enol(ate) or
aldehyde by 3-HP is essential for inactivation.
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Figure 3. X-ray structure of 3-HP–MR. (a) Stereoview of the active site showing the
major (70%) and minor (30%) conformations of the 3-HP adduct with Lys 166. The
aldehyde/enol(ate) oxygen of the major conformation is within H-bonding distance of
the Brønsted acid–base catalyst His 297. (b) Stereoview of representative 2Fo – Fc
electron density maps, contoured at 1.0σ, for the 3-HP–MR structure showing a closeup view of the Lys 166–3-HP adduct.

Table 1. X-ray Data Collection and Refinement Statistics
3-HP–MR
PDB entry

4X2P

space group
cell dimensions

I422

a, b, c (Å)

123.88, 123.88, 105.30

α, β, γ (deg)

90, 90, 90

resolution range (Å)

50.0–1.65 (1.68–1.65)a

redundancy

13.0 (8.4)a

completeness (%)

99.6 (94.0)a

no. of unique reflections

49040

Rmerge
average I/σ

0.082 (0.437)a
29.55 (4.125)a
Refinement

resolution range (Å)

40–1.65 (1.69–1.65)a

Rcryst

0.145 (0.181)a

Rfree

0.177 (0.232)a

no. of protein atoms

2757
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3-HP–MR
no. of water molecules

297

Wilson B value (Å2)

17.0

average B factor

(Å2)

protein

16.1

ligand

23.9

Mg2+

2.3

solvent

26.1

Ramachandran plot (%)
most favored

91.5

additionally allowed

7.5

generously allowed

0.7

disallowed

0.3

root-mean-square deviations
bond lengths (Å)

0.028

bond angles (deg)

2.54

a Values

in parentheses are for the highest-resolution bin.

C2 of the 3-HP enamine occupies a position approximately
equivalent to that of the α-methyl group of (S)-atrolactate (Figure 4).
Both ground state and transition state analogues bind to MR with one
carboxylate oxygen and the α-OH group coordinated to Mg2+ in the
active site. In the 3-HP–MR structure, however, the α-OH group is
replaced with a free water molecule, while one carboxylate oxygen
maintains coordination with Mg 2+ in a manner analogous to that of the
substrate and transition state analogues. This coordination with the
active site Mg2+ likely facilitates deprotonation of the Schiff base by His
297, similar to its role in stabilizing the aci-carboxylate intermediate
during the racemization of mandelate. Interestingly, the active site lid
(20s loop) that typically closes over the active site when either ground
state or transition state analogues are bound adopts an “open”
conformation in the 3-HP–MR structure (Figure 5). This conformation
may arise because the hydrophobic group (i.e., aromatic ring) present
on substrates and intermediate analogues is not present to drive lid
closure.51 The 20s loop in the structure of MR (PDB entry 4M6U) with
bound tartronate, which also lacks the phenyl ring, exhibited an
approximately 1:1 ratio of both the open and closed conformations; 23
however, it is important to note that the 20s loop of MR with only
sulfate bound (PDB entry 2MNR) was closed, suggesting that other
factors may also contribute to the observed conformation of the loop in
crystals.8
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Figure 4. Stereoview of the active site of MR containing the adduct with 3-HP (green),
overlaid with the bound substrate analogue (S)-atrolactate [(S)-Atro; PDB entry
1MDR, orange],(71) and the intermediate analogue benzohydroxamate (BzH; PDB
entry 3UXK, pink).(72) The Brønsted acid–base catalysts (His 297 and Lys 166) are
colored cyan.

Figure 5. Structural overlay of the 3-HP–MR structure (colored white, with the 20s
loop colored green) with the structures of MR in the presence of ( S)-atrolactate (PDB
entry 1MDR, orange), 71 benzohydroxamate (PDB entry 3UXK, pink), 72 and benzilate
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(PDB entry 4HNC, yellow). 23 Aside from 3-HP, all other ligands are not shown for the
sake of clarity. The 3-HP–MR structure exhibits an “open” conformation of the 20s loop
lid, similar to the conformation observed when the bulky substrate–product analogue
benzilate is bound to C92S/C264S/K166C MR. 23

Mechanistic Link between Superfamilies
The formation of a Schiff base is unprecedented in the enolase
superfamily. However, irreversible inhibition by 3-HP has been
demonstrated for members of the NAL superfamily. This superfamily
includes NAL, DHDPS, trans-o-hydroxybenzylidene-pyruvate
hydratase-aldolase, and d-4-deoxy-5-oxoglucarate dehydratase,2,7,52
which have also been included within the class I aldolases53 by the
SCOP database54,55 on the basis of their similar Schiff-base chemistry
and common (α/β)8-fold. 3-HP inactivates NAL from Clostridium
fringens56 and E. coli44 and DHDPS from E. coli,45 and the X-ray crystal
structures of the covalently modified NAL and DHDPS enzymes
revealed the presence of an aldehyde/enol(ate)–lysine adduct similar
to the one we observe for MR inactivated by 3-HP.44,45 Although the
mechanism-based inhibition of these two NAL superfamily members by
3-HP also proceeds via initial Schiff-base formation followed by
deprotonation,44,45 the apparent second-order rate constant for the
inactivation of MR exceeds that observed for inactivation of DHDPS
(0.56 M–1 s–1) by ∼138-fold. This observation is in accord with the
active site of MR being optimized to promote enolate formation.
Many of the enzymes sharing the highly prevalent (α/β) 8-barrel
(or TIM barrel) folding topology53,57-62 are believed to have arisen via
divergent evolution from a common ancestor or a limited number of
progenitor enzymes.53,60,63-67 Many aldolases share this fold with
members of the enolase and NAL superfamilies, as well as sharing a
similar mechanistic theme, i.e., the formation of a “masked”
carbanionic intermediate (Scheme 3). Formation of such an
intermediate is facilitated via formation of an imine/enamine “electron
sink” with an active site lysine residue in the class I aldolases, and by
utilizing a transition metal ion (usually Zn 2+) as an essential Lewis acid
cofactor in the class II aldolases. Although the reaction mechanisms
differ between these two classes of aldolases, their ancestral aldolase
has been postulated to have been a Schiff-base-forming enzyme that
subsequently gave rise to a lineage of metal-dependent class II
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aldolases.53 Several comparisons of sequences, structures, and
functions have suggested common ancestry between the class I and II
aldolases and the enolase superfamily.53,57,63,67 Considering the metal
ion dependence of the class II aldolases, the mechanistic link to the
enolase superfamily was clear (Scheme 3),68 but such a link between
the class I aldolases and the enolase superfamily was not evident.
Allen and co-workers conducted a comparison of the primary and
tertiary structures of class I aldolases and members of the NAL
superfamily, and concluded that these enzymes could all be included in
a large superfamily utilizing Schiff-base chemistry and related by
divergent evolution from a common progenitor enzyme. 69
Interestingly, these authors employed MR as a “negative control”
because it was deemed not to be mechanistically related to the
aldolases. This study suggests that a mechanistic relationship does
indeed exist. Thus, while over evolutionary time scales the catalytic
mechanism of enzymes may not be fully conserved, 67 the ability of MR
to form and deprotonate a Schiff-base intermediate furnishes a
mechanistic link to other α/β-barrel enzymes utilizing Schiff-base
chemistry and may be a relic of an activity possessed by a
promiscuous progenitor enzyme.70 Delineating such chemistry-based
relationships and their overlap with structure space and sequence
space affords a more complete understanding of nature’s strategies for
the evolution of new catalysts.3

Scheme 3. Summary of the Reactions Catalyzed by the Enolase and NAL
Superfamilies and the Class I and II Aldolases
Biochemistry, Vol 54, No. 17 (May 5, 2015): pg. 2747-2757. DOI. This article is © American Chemical Society and
permission has been granted for this version to appear in e-Publications@Marquette. American Chemical Society does
not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission
from American Chemical Society.

22

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Accession Codes
The atomic coordinates of the 3-HP–MR structure have been deposited
in the Protein Data Bank as entry 4X2P.
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BzH
CD
DHDPS
ESI

benzohydroxamate
circular dichroism
dihydrodipicolinate synthase
electrospray ionization

3-FP
3-HP

3-fluoropyruvate
3-hydroxypyruvate

3-HP–MR
LC
MR
MS

wild-type MR modified by 3-HP
liquid chromatography
mandelate racemase
mass spectrometry
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NAL

N-acetylneuraminate lyase

TFHTP

3,3,3-trifluoro-2-hydroxy-2-(trifluoromethyl)propanoate.
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Supplementary Figure 1S.

Competitive inhibition of MR by mesoxalate (Mox).

Representative Lineweaver-Burk plot.

(A)

(B) Replot of the apparent Km/Vmax values against

inhibitor concentration. Assay conditions are as described in the Materials and Methods.
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Supplementary Figure 2S. Competitive inhibition of MR by 3-fluoropyruvate (3-FP). (A)
Representative Lineweaver-Burk plot.

(B) Replot of the apparent Km/Vmax values against

inhibitor concentration. Assay conditions are as described in the Materials and Methods.
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Supplementary Figure 3S.

Time-dependence for the inhibition of MR by α-keto acids.

Pyruvate (Pyr), mesoxalate (Mox), benzoylformate (BzF), and 3-fluoropyruvate (3-FP) do not
show significant reduction in MR activity when incubated at concentrations of 2 mM with wildtype MR for 10 min at 25 °C.
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Supplementary Figure 4S.

Stereoview of a representative 2Fo-Fc electron density map,

contoured at 1.0 σ, for the active site of 3-HP-MR. The Brønsted acid-base catalysts (His 297
and Lys 166) are colored cyan and the 3-HP adduct is colored green.
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